Corporate Profile

Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. We are committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, we have established a global sales presence delivering a comprehensive portfolio of highly differentiated electrophysiology products that provide our customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Relations

Press Releases

12 Nov '20
CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2020.
29 Oct '20
CARLSBAD, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the third quarter of 2020 after market close on Thursday, November 12, 2020. In conjunction with the release, Acutus will host a conference

Recent Events

More events are coming soon.

SEC Filings

Filing date Description Form

Quarterly report which provides a continuing view of a company's financial position

10-Q

Report of unscheduled material events or corporate event

8-K

Quarterly report which provides a continuing view of a company's financial position

10-Q